Prague Med. Rep. 2012, 113, 217-222

https://doi.org/10.14712/23362936.2015.19

Association of –607 C/A Polymorphism of IL-18 Gene (rs1946518) with Breast Cancer Risk in Zahedan, Southeast Iran

M. Taheri1,2, Mohammad Hashemi2,3, E. Eskandari-Nasab2, A. Fazaeli2, F. Arbabi4, M. Bahrani-Zeidabadi3, G. Bahari3

1Department of Genetics, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran
2Genetic of Non-Communicable Disease Research Center, Zahedan University of Medical Sciences, Zahedan, Iran
3Department of Clinical Biochemistry, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran
4Department of Internal Medicine, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran

Received January 18, 2012
Accepted June 25, 2012

References

1. De Vivo, I., Hankinson, S. E., Colditz, G. A., Hunter, D. J. (2003) A functional polymorphism in the progesterone receptor gene is associated with an increase in breast cancer risk. Cancer Res. 63, 5236–5238.
2. Farjadfar, A., Mojtahedi, Z., Ghayumi, M. A., Erfani, N., Haghshenas, M. R., Ghaderi, A. (2009) Interleukin-18 promoter polymorphism is associated with lung cancer: a case-control study. Acta Oncol. 48, 971–976. <https://doi.org/10.1080/02841860902878145>
3. Giedraitis, V., He, B., Huang, W. X., Hillert, J. (2001) Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. J. Neuroimmunol. 112, 146–152. <https://doi.org/10.1016/S0165-5728(00)00407-0>
4. Gunel, N., Coskun, U., Sancak, B., Gunel, U., Hasdemir, O., Bozkurt, S. (2002) Clinical importance of serum interleukin-18 and nitric oxide activities in breast carcinoma patients. Cancer 95, 663–667. <https://doi.org/10.1002/cncr.10705>
5. Harirchi, I., Kolahdoozan, S., Karbakhsh, M., Chegini, N., Mohseni, S. M., Montazeri, A., Momtahen, A. J., Kashefi, A., Ebrahimi, M. (2011) Twenty years of breast cancer in Iran: downstaging without a formal screening program. Ann. Oncol. 22, 93–97. <https://doi.org/10.1093/annonc/mdq303>
6. Hashemi, M., Moazeni-Roodi, A. K., Fazaeli, A., Sandoughi, M., Bardestani, G. R., Kordi-Tamandani, D. M., Ghavami, S. (2010) Lack of association between paraoxonase-1 Q192R polymorphism and rheumatoid arthritis in southeast Iran. Genet. Mol. Res. 9, 333–339. <https://doi.org/10.4238/vol9-1gmr728>
7. Khalili-Azad, T., Razmkhah, M., Ghiam, A. F., Doroudchi, M., Talei, A. R., Mojtahedi, Z., Ghaderi, A. (2009) Association of interleukin-18 gene promoter polymorphisms with breast cancer. Neoplasma 56, 22–25. <https://doi.org/10.4149/neo_2009_01_22>
8. Kolahdoozan, S., Sadjadi, A., Radmard, A. R., Khademi, H. (2010) Five common cancers in Iran. Arch. Iran. Med. 13, 143–146.
9. Nikiteas, N., Yannopoulos, A., Chatzitheofylaktou, A., Tsigris, C. (2007) Heterozygosity for interleukin-18 –607 A/C polymorphism is associated with risk for colorectal cancer. Anticancer Res. 27, 3849–3853.
10. Park, S., Cheon, S., Cho, D. (2007) The dual effects of interleukin-18 in tumor progression. Cell. Mol. Immunol. 4, 329–335.
11. Smith, A. J., Humphries, S. E. (2009) Cytokine and cytokine receptor gene polymorphisms and their functionality. Cytokine Growth Factor Rev. 20, 43–59. <https://doi.org/10.1016/j.cytogfr.2008.11.006>
12. Snoussi, K., Mahfoudh, W., Bouaouina, N., Fekih, M., Khairi, H., Helal, A. N., Chouchane, L. (2010) Combined effects of IL-8 and CXCR2 gene polymorphisms on breast cancer susceptibility and aggressiveness. BMC Cancer 10, 283. <https://doi.org/10.1186/1471-2407-10-283> <PubMed>
13. Srabovic, N., Mujagic, Z., Mujanovic-Mustedanagic, J., Muminovic, Z., Cickusic, E. (2011) Interleukin 18 expression in the primary breast cancer tumour tissue. Med. Glas. Ljek. komore Zenicko-doboj. kantona 8, 109–115.
14. Srivastava, S., Salim, N., Robertson, M. J. (2010) Interleukin-18: biology and role in the immunotherapy of cancer. Curr. Med. Chem. 17, 3353–3357. <https://doi.org/10.2174/092986710793176348>
15. Taheri, M., Hashemi-Shahri, S. M., Hamzehnejadi, M., Naderi, M., Moazeni-Roodi, A., Bahari, G., Hashemi, M. (2012) Lack of association between interleukin-18 –607 C/A gene polymorphism and pulmonary tuberculosis in Zahedan, southeast Iran. Prauge Med. Rep. 113, 16–22. <https://doi.org/10.14712/23362936.2015.33>
16. Vairaktaris, E., Serefoglou, Z. C., Yapijakis, C., Agapi, C., Vassiliou, S., Nkenke, E., Antonis, V., Sofia, S., Neukam, F. W., Patsouris, E. (2007) The interleukin-18 –607A/C polymorphism is not associated with risk for oral cancer. Anticancer Res. 27, 4011–4014.
17. Yao, L., Zhang, Y., Chen, K., Hu, X., Xu, L. X. (2011) Discovery of IL-18 as a novel secreted protein contributing to doxorubicin resistance by comparative secretome analysis of MCF-7 and MCF-7/Dox. PLoS One 6, e24684. <https://doi.org/10.1371/journal.pone.0024684> <PubMed>
18. Zhao, E., Cui, D., Yuan, L., Lu, W. (2012) MDM2 SNP309 polymorphism and breast cancer risk: a meta-analysis. Mol. Biol. Rep. 39, 3471–3477. <https://doi.org/10.1007/s11033-011-1119-1>
front cover

ISSN 1214-6994 (Print) ISSN 2336-2936 (Online)

Archive